author-photo

D.-W. Kim

Seoul National University Hospital

4

Papers

98

Citations

Citation Trend

Filter By

Papers (4) Sort By

Journal Conference Others

Genetic landscape of patients with ALK-rearranged non–small-cell lung cancer (NSCLC) and response to ceritinib in ASCEND-1 study

2021 Lung Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Safety and Efficacy of Quavonlimab, a Novel Anti-CTLA-4 Antibody (MK-1308), in Combination with Pembrolizumab in First-Line Advanced Non-Small Cell Lung Cancer.

2020 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (5)
Primary resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in patients with non-small-cell lung cancer harboring TKI-sensitive EGFR mutations: an exploratory study

2013 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (93)
First-Line Dacomitinib (PF-00299804), an Irreversible Pan-Her Tyrosine Kinase Inhibitor, for Patients with EGFR-Mutant Lung Cancers

2012 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)